EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prostaglandin E₂ impacts multiple stages of the natural killer cell antitumor immune response

Chloe Patterson, Khodor S Hazime iD, Santiago Zelenay, Daniel M Davis iD

European Journal of Immunology · 2024-02 · 54 (2)

DOI: 10.1002/eji.202350635 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, online erschienen am 14.12.2023. Verfasst von Chloe Patterson und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Lydia Becker Institute of Immunology and Inflammation, The University of Manchester, Manchester, United Kingdom. Hauptthemen laut MEDLINE: Dinoprostone, Killer Cells, Natural. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor immune escape is a major factor contributing to cancer progression and unresponsiveness to cancer therapies. Tumors can produce prostaglandin E 2 (PGE 2 ), an inflammatory mediator that directly acts on Natural killer (NK) cells to inhibit antitumor immunity. However, precisely how PGE 2 influences NK cell tumor‐restraining functions remains unclear. Here, we report that following PGE₂ treatment, human NK cells exhibited altered expression of specific activating receptors and a reduced ability to degranulate and kill cancer targets. Transcriptional analysis uncovered that PGE₂ also differentially modulated the expression of chemokine receptors by NK cells, inhibiting CXCR3 but increasing CXCR4. Consistent with this, PGE₂‐treated NK cells exhibited decreased migration to CXCL10 but increased ability to migrate toward CXCL12. Using live cell imaging, we showed that in the presence of PGE 2 , NK cells were slower and less likely to kill cancer target cells following conjugation. Imaging the sequential stages of NK cell killing revealed that PGE₂ impaired NK cell polarization, but not the re‐organization of synaptic actin or the release of perforin itself. Together, these findings demonstrate that PGE₂ affects multiple but select NK cell functions. Understanding how cancer cells subvert NK cells is necessary to more effectively harness the cancer‐inhibitory function of NK cells in treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DinoprostoneKiller Cells, NaturalHumansCell Line, TumorImmunity

Stichwörter der Autor:innen

CancerCytotoxicityImmune escapeNatural killer cellProstaglandin E₂

Substanzen

Dinoprostone

Autor:innen und Institutionen

  • The Lydia Becker Institute of Immunology and Inflammation, The University of Manchester, Manchester, United Kingdom.
  • Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, South Kensington, London, United Kingdom.
  • Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, United Kingdom.

ORCID-Profile: Khodor S Hazime, Daniel M Davis

Förderung

  • Cancer Research UK
  • Medical Research Council

Zitieren

APA

Patterson, C., Hazime, K. S., Zelenay, S., & Davis, D. M. (2024). Prostaglandin E₂ impacts multiple stages of the natural killer cell antitumor immune response. European Journal of Immunology, 54(2). https://doi.org/10.1002/eji.202350635

Vancouver

Patterson C, Hazime KS, Zelenay S, Davis DM. Prostaglandin E₂ impacts multiple stages of the natural killer cell antitumor immune response. European Journal of Immunology. 2024;54(2). doi:10.1002/eji.202350635

BibTeX
@article{Patterson2024,
  author = {Patterson, Chloe and Hazime, Khodor S and Zelenay, Santiago and Davis, Daniel M},
  title = {Prostaglandin E₂ impacts multiple stages of the natural killer cell antitumor immune response},
  journal = {European Journal of Immunology},
  year = {2024},
  volume = {54},
  number = {2},
  doi = {10.1002/eji.202350635}
}
Kostenlos starten →